Bronchoplastic lobectomy in non-small cell lung cancer: review of 218 patients

Yuming Zhu, Yi Zhang, Gening JiangChinese 2008 · DOI

Abstract

Objective To investigate the indications, postoperative complications and predicting factors after sleeve lobectomy for NSCLC. Methods 218 patients with NSCLC underwent sleeve lobectomy. Results The mortality was 3.2% and morbidity 20.2%. The overall survival rate at 1, 3 and 5 years was 76%, 55% and 42, respectively. Multivariate analysis indicated that N stage (P=0.000) and postoperative adjuvant chemotherapy (P=0.021) were significant factors affecting survival. Conclusion For patients with NSCLC, bronchoplastic lobectomy are an adequate cancer operation. Preoperative and postoperative adjuvant chemo- therapy would play an important role in prolenging survival, particularly in patients with positive N1 or N2 lymph nodes. Key words: Carcinoma, non-small-cell lung; Pneumonectomy; Postoperative complications; Prognosis
BibTeX
@inproceedings{zhu2008bronchoplastic,
  author = {Yuming Zhu and Yi Zhang and Gening Jiang},
  title = {{Bronchoplastic lobectomy in non-small cell lung cancer: review of 218 patients}},
  booktitle = {Chinese},
  year = {2008},
  doi = {10.3760/cma.j.issn.1001-4497.2008.04.006},
}

Loading related content...

Figure